PubMed:1726578 / 134-462 JSONTXT

{"project":"Glycan-Motif","denotations":[{"id":"T2","span":{"begin":62,"end":65},"obj":"https://glytoucan.org/Structures/Glycans/G01187XC"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T2","span":{"begin":62,"end":65},"obj":"Glycan_Motif"}],"attributes":[{"id":"A2","pred":"image","subj":"T2","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G01187XC"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T2","span":{"begin":62,"end":65},"obj":"https://glytoucan.org/Structures/Glycans/G01187XC"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":328},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":328},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":328},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":307,"end":313},"obj":"HP_0002664"},{"id":"T1","span":{"begin":307,"end":313},"obj":"HP_0002664"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T8","span":{"begin":19,"end":30},"obj":"FMAID:82792"},{"id":"_T9","span":{"begin":19,"end":30},"obj":"FMAID:196787"},{"id":"_T10","span":{"begin":235,"end":244},"obj":"FMAID:167148"},{"id":"_T11","span":{"begin":235,"end":244},"obj":"FMAID:62852"},{"id":"_T12","span":{"begin":245,"end":256},"obj":"FMAID:63916"},{"id":"_T13","span":{"begin":245,"end":256},"obj":"FMAID:162384"},{"id":"_T14","span":{"begin":257,"end":279},"obj":"FMAID:67856"},{"id":"_T15","span":{"begin":257,"end":279},"obj":"FMAID:165776"},{"id":"_T16","span":{"begin":257,"end":279},"obj":"FMAID:167238"},{"id":"_T17","span":{"begin":257,"end":279},"obj":"FMAID:165233"},{"id":"_T18","span":{"begin":257,"end":279},"obj":"FMAID:67214"},{"id":"_T19","span":{"begin":257,"end":279},"obj":"FMAID:62914"},{"id":"_T20","span":{"begin":257,"end":279},"obj":"FMAID:62915"},{"id":"_T21","span":{"begin":257,"end":279},"obj":"FMAID:167237"},{"id":"_T22","span":{"begin":314,"end":327},"obj":"FMAID:212684"},{"id":"_T23","span":{"begin":314,"end":327},"obj":"FMAID:200942"},{"id":"_T24","span":{"begin":319,"end":327},"obj":"FMAID:146300"},{"id":"_T25","span":{"begin":319,"end":327},"obj":"FMAID:50594"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"uniprot-human","denotations":[{"id":"T3","span":{"begin":86,"end":92},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T4","span":{"begin":117,"end":123},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T5","span":{"begin":129,"end":135},"obj":"http://www.uniprot.org/uniprot/Q92988"},{"id":"T14","span":{"begin":149,"end":173},"obj":"http://www.uniprot.org/uniprot/P06731"},{"id":"T15","span":{"begin":257,"end":279},"obj":"http://www.uniprot.org/uniprot/P16422"},{"id":"T16","span":{"begin":257,"end":279},"obj":"http://www.uniprot.org/uniprot/P43121"},{"id":"T17","span":{"begin":257,"end":279},"obj":"http://www.uniprot.org/uniprot/Q14CZ8"},{"id":"T18","span":{"begin":257,"end":279},"obj":"http://www.uniprot.org/uniprot/Q8N126"},{"id":"T19","span":{"begin":257,"end":279},"obj":"http://www.uniprot.org/uniprot/Q8NFZ8"},{"id":"T20","span":{"begin":257,"end":279},"obj":"http://www.uniprot.org/uniprot/P50895"},{"id":"T21","span":{"begin":257,"end":279},"obj":"http://www.uniprot.org/uniprot/Q8N3J6"},{"id":"T22","span":{"begin":257,"end":281},"obj":"http://www.uniprot.org/uniprot/Q8N2F4"},{"id":"T23","span":{"begin":257,"end":279},"obj":"http://www.uniprot.org/uniprot/Q92823"},{"id":"T24","span":{"begin":257,"end":281},"obj":"http://www.uniprot.org/uniprot/Q59FL7"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"uniprot-mouse","denotations":[{"id":"T1","span":{"begin":257,"end":281},"obj":"http://www.uniprot.org/uniprot/Q9Z2H8"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T4","span":{"begin":86,"end":90},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T5","span":{"begin":86,"end":90},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T6","span":{"begin":117,"end":121},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T7","span":{"begin":117,"end":121},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T8","span":{"begin":129,"end":133},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T9","span":{"begin":129,"end":133},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"GO-BP","denotations":[{"id":"T3","span":{"begin":4,"end":10},"obj":"http://purl.obolibrary.org/obo/GO_0097503"},{"id":"T4","span":{"begin":50,"end":56},"obj":"http://purl.obolibrary.org/obo/GO_0097503"},{"id":"T8","span":{"begin":11,"end":18},"obj":"http://purl.obolibrary.org/obo/GO_0036065"},{"id":"T9","span":{"begin":245,"end":270},"obj":"http://purl.obolibrary.org/obo/GO_0071603"},{"id":"T10","span":{"begin":257,"end":270},"obj":"http://purl.obolibrary.org/obo/GO_0007155"},{"id":"T11","span":{"begin":257,"end":279},"obj":"http://purl.obolibrary.org/obo/GO_0060352"},{"id":"T12","span":{"begin":257,"end":279},"obj":"http://purl.obolibrary.org/obo/GO_0007155"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"GO-MF","denotations":[{"id":"T1","span":{"begin":209,"end":215},"obj":"http://purl.obolibrary.org/obo/GO_0005488"},{"id":"T2","span":{"begin":224,"end":231},"obj":"http://purl.obolibrary.org/obo/GO_0070026"},{"id":"T3","span":{"begin":224,"end":231},"obj":"http://purl.obolibrary.org/obo/GO_0003680"},{"id":"T4","span":{"begin":224,"end":231},"obj":"http://purl.obolibrary.org/obo/GO_0017091"},{"id":"T5","span":{"begin":224,"end":231},"obj":"http://purl.obolibrary.org/obo/GO_0005488"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"GO-CC","denotations":[{"id":"T2","span":{"begin":257,"end":261},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T3","span":{"begin":314,"end":318},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T4","span":{"begin":314,"end":327},"obj":"http://purl.obolibrary.org/obo/GO_0009986"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"EDAM-topics","denotations":[{"id":"T1","span":{"begin":166,"end":173},"obj":"http://edamontology.org/topic_2830"},{"id":"T2","span":{"begin":271,"end":279},"obj":"http://edamontology.org/topic_2839"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"NGLY1-deficiency","denotations":[{"id":"PD-NGLY1-deficiency-B_T1","span":{"begin":110,"end":116},"obj":"chem:24139"}],"namespaces":[{"prefix":"hgnc","uri":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:"},{"prefix":"omim","uri":"https://www.omim.org/entry/"},{"prefix":"chem","uri":"https://pubchem.ncbi.nlm.nih.gov/compound/"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T1","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G49112ZN\""},{"id":"GlycanIUPAC_T2","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G50059AJ\""},{"id":"GlycanIUPAC_T3","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G76218YK\""},{"id":"GlycanIUPAC_T4","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G50102KR\""},{"id":"GlycanIUPAC_T5","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G10717VS\""},{"id":"GlycanIUPAC_T6","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G60524RK\""},{"id":"GlycanIUPAC_T7","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G84407TT\""},{"id":"GlycanIUPAC_T8","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G64717JT\""},{"id":"GlycanIUPAC_T9","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G45003TT\""},{"id":"GlycanIUPAC_T10","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G73923FP\""},{"id":"GlycanIUPAC_T11","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G78231MB\""},{"id":"GlycanIUPAC_T12","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G80487UG\""},{"id":"GlycanIUPAC_T13","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G29758MI\""},{"id":"GlycanIUPAC_T14","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G02671KD\""},{"id":"GlycanIUPAC_T15","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G57926TZ\""},{"id":"GlycanIUPAC_T16","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G41718FD\""},{"id":"GlycanIUPAC_T17","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G99840FL\""},{"id":"GlycanIUPAC_T18","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G64321UX\""},{"id":"GlycanIUPAC_T19","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G11231EG\""},{"id":"GlycanIUPAC_T20","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G62741TN\""},{"id":"GlycanIUPAC_T21","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G51576ZQ\""},{"id":"GlycanIUPAC_T22","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G66056LD\""},{"id":"GlycanIUPAC_T23","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G02768BF\""},{"id":"GlycanIUPAC_T24","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G26168RO\""},{"id":"GlycanIUPAC_T25","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G42890HL\""},{"id":"GlycanIUPAC_T26","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G17533VU\""},{"id":"GlycanIUPAC_T27","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G34306RG\""},{"id":"GlycanIUPAC_T28","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G88735KU\""},{"id":"GlycanIUPAC_T29","span":{"begin":96,"end":99},"obj":"\"http://rdf.glycoinfo.org/glycan/G82605UA\""},{"id":"GlycanIUPAC_T30","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G26693XF\""},{"id":"GlycanIUPAC_T32","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G01864SU\""},{"id":"GlycanIUPAC_T34","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G17605FD\""},{"id":"GlycanIUPAC_T36","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G41950LU\""},{"id":"GlycanIUPAC_T38","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G57195RJ\""},{"id":"GlycanIUPAC_T40","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G85391SA\""},{"id":"GlycanIUPAC_T42","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G89565QL\""},{"id":"GlycanIUPAC_T44","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G80869MR\""},{"id":"GlycanIUPAC_T46","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G55978NL\""},{"id":"GlycanIUPAC_T48","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G54644LT\""},{"id":"GlycanIUPAC_T50","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G25694UG\""},{"id":"GlycanIUPAC_T52","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G25126RB\""},{"id":"GlycanIUPAC_T54","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G51848AD\""},{"id":"GlycanIUPAC_T56","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G94667GM\""},{"id":"GlycanIUPAC_T58","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G30124BO\""},{"id":"GlycanIUPAC_T60","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G82777EZ\""},{"id":"GlycanIUPAC_T62","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G10151YZ\""},{"id":"GlycanIUPAC_T64","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G17585ZM\""},{"id":"GlycanIUPAC_T66","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G04411CJ\""},{"id":"GlycanIUPAC_T68","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G38254HJ\""},{"id":"GlycanIUPAC_T70","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G75188FS\""},{"id":"GlycanIUPAC_T72","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G70374VG\""},{"id":"GlycanIUPAC_T74","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G45176LJ\""},{"id":"GlycanIUPAC_T76","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G30874VW\""},{"id":"GlycanIUPAC_T78","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G69333MI\""},{"id":"GlycanIUPAC_T80","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G10676XO\""},{"id":"GlycanIUPAC_T82","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G14843DJ\""},{"id":"GlycanIUPAC_T84","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G47546FR\""},{"id":"GlycanIUPAC_T86","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G73695ZM\""},{"id":"GlycanIUPAC_T88","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G31923TJ\""},{"id":"GlycanIUPAC_T90","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G60519EP\""},{"id":"GlycanIUPAC_T92","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G07933IA\""},{"id":"GlycanIUPAC_T94","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G40745NH\""},{"id":"GlycanIUPAC_T96","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G54496YV\""},{"id":"GlycanIUPAC_T98","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G62953SQ\""},{"id":"GlycanIUPAC_T100","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G70070AY\""},{"id":"GlycanIUPAC_T102","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G78792WC\""},{"id":"GlycanIUPAC_T104","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G25238AV\""},{"id":"GlycanIUPAC_T106","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G40510DP\""},{"id":"GlycanIUPAC_T108","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G61120TK\""},{"id":"GlycanIUPAC_T110","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G41342KV\""},{"id":"GlycanIUPAC_T112","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G90703NA\""},{"id":"GlycanIUPAC_T114","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G01591HR\""},{"id":"GlycanIUPAC_T116","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G56520XN\""},{"id":"GlycanIUPAC_T118","span":{"begin":110,"end":116},"obj":"\"http://rdf.glycoinfo.org/glycan/G81830JX\""}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"GlycoBiology-Motifs","denotations":[{"id":"T2","span":{"begin":62,"end":65},"obj":"http://rdf.glycoinfo.org/glycan/G00051MO"},{"id":"T4","span":{"begin":19,"end":30},"obj":"http://rdf.glycoinfo.org/glycan/G00055MO"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T2","span":{"begin":307,"end":313},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0002664"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T3","span":{"begin":235,"end":244},"obj":"Body_part"},{"id":"T4","span":{"begin":245,"end":261},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL_0000738"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CL_0000115"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}

{"project":"Glycosmos15-CL","denotations":[{"id":"T1","span":{"begin":235,"end":244},"obj":"Cell"},{"id":"T2","span":{"begin":245,"end":261},"obj":"Cell"},{"id":"T3","span":{"begin":307,"end":318},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0000738"},{"id":"A2","pred":"cl_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CL:0000115"},{"id":"A3","pred":"cl_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CL:0001063"}],"text":"The sialyl-fucosyl-lactosamine-epitope present in sialyl (SA)-Lex (NeuAc alpha 2-3Gal beta 1-4 [Fuc alpha 1-3]GlcNAc beta 1-3Gal beta 1-4Glc-Cer), a carcinoembryonic antigen, has been recognized recently as a ligand for the binding of leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) to myeloid and tumour cell surfaces."}